"Our service and quality set the standard of excellence for community health systems. In addition to being a full-service hospital we operate an extensive clinic system, from urgent care centers to specialty physician practices throughout the greater Jefferson City area and surrounding communities. Throughout our history the mission has stayed the same: to improve the health and promote the wellness of the people and communities we serve. Our board-certified physicians are ready to assist you with your family medical needs. Our physicians are currently accepting new patient and our courteous and professional staff look forward to serving you and your family."

During the past decade, Capital Region Medical Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Capital Region Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 6 trials, followed by "A.T. Still University of Health Sciences" with 1 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "Fore Biotherapeutics" with 1 trials sponsored and "SecuraBio" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Capital Region Medical Center" #1 collaborator was "Cancer and Leukemia Group B" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator and "American College of Surgeons" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Capital Region Medical Center" are "Advanced Unresectable Solid Tumors" (1 trials), "BRAF-mutated Tumors" (1 trials), "Breast Adenocarcinoma" (1 trials), "Breast Carcinoma" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Capital Region Medical Center" in a lesser frequency.

Most popular intervention types in "Capital Region Medical Center" are "Drug" (8 trials), "Other" (4 trials), "Biological" (3 trials), "Genetic" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (3 trials), "Carboplatin" (3 trials), "Laboratory Biomarker Analysis" (3 trials), "Paclitaxel" (3 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Capital Region Medical Center" are 8 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Capital Region Medical Center". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Capital Region Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Capital Region Medical Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Capital Region Medical Center has several departments that took part in Clinical trials: "Capital Region Medical Center-Goldschmidt Cancer Center" - 69 trials